Active Ingredient History
Lurbinectedin, sold under the brand name Zepzelca, is a medication used for the treatment of small cell lung cancer. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Breast Neoplasms (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 1)
Carcinoma, Transitional Cell (Phase 2)
Colorectal Neoplasms (Phase 1)
Endometrial Neoplasms (Phase 1/Phase 2)
Genital Neoplasms, Female (Phase 1)
Glioblastoma (Phase 1)
Homologous Recombination (Phase 2)
Leiomyosarcoma (Phase 2)
Leukemia, Myeloid, Acute (Phase 1)
Liver Diseases (Phase 1)
Lung Neoplasms (Phase 2)
Mesothelioma (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 2)
Neuroendocrine Tumors (Phase 2)
Ovarian Neoplasms (Phase 3)
Pancreatic Neoplasms (Phase 1)
Sarcoma (Phase 2)
Sarcoma, Ewing (Phase 2)
Small Cell Lung Carcinoma (Phase 3)
Squamous Cell Carcinoma of Head and Neck (Phase 1)
Stomach Neoplasms (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
